Last reviewed · How we verify

NCT06346132

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

Recruiting now NA Last updated 20 March 2026
What this trial tests

NA trial testing Virtual reality application in Virtual Reality in 150 participants. Currently enrolling.

Timeline
29 March 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorSchlotterbeck Hervé
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment150
Start date29 March 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Schlotterbeck Hervé

Who can join

18 and older, any sex, with Virtual Reality or Medical Device. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effect on patient's comfort of a virtual reality experience during a procedure of cardiac electronic device implantation under local anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual reality application

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06346132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing